Beacon Pharmaceuticals PLC (DSE:BEACONPHAR)

Beacon Pharmaceuticals Ratios and Metrics

Market cap in millions BDT. Fiscal year is July - June.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jan 21, 2026	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020
Market Capitalization	23,678	35,528	56,595	59,667	28,552	14,022
Market Cap Growth	-21.03%	-37.22%	-5.15%	108.98%	103.62%	201.99%
Enterprise Value	30,183	45,350	62,791	63,025	30,523	15,593
Last Close Price	102.50	148.05	234.30	245.53	116.74	56.84
PE Ratio	41.54	68.19	111.01	63.81	33.08	36.83
PS Ratio	2.04	3.32	6.65	7.44	4.01	2.51
PB Ratio	3.63	5.83	9.53	10.04	5.33	3.03
P/TBV Ratio	3.64	5.86	9.54	10.04	5.33	3.03
P/FCF Ratio	15.62	-	-	-	-	-
P/OCF Ratio	12.91	-	91.11	55.14	145.26	48.16
EV/Sales Ratio	2.61	4.24	7.38	7.86	4.29	2.79
EV/EBITDA Ratio	11.08	19.25	41.92	30.64	17.47	18.46
EV/EBIT Ratio	13.77	24.80	64.13	38.97	22.42	46.76
EV/FCF Ratio	19.91	-	-	-	-	-
Debt / Equity Ratio	1.54	1.69	1.25	0.64	0.47	0.47
Debt / EBITDA Ratio	3.70	4.38	4.98	1.86	1.43	2.58
Debt / FCF Ratio	6.64	-	-	-	-	-
Asset Turnover	0.62	0.64	0.67	0.83	0.91	0.93
Inventory Turnover	2.07	2.14	2.15	2.40	2.99	2.68
Quick Ratio	0.68	0.36	0.36	0.54	0.82	0.90
Current Ratio	1.42	1.37	1.20	1.38	1.87	1.84
Return on Equity (ROE)	8.88%	8.66%	8.58%	16.55%	17.29%	10.01%
Return on Assets (ROA)	7.28%	6.81%	4.81%	10.45%	10.83%	3.46%
Return on Invested Capital (ROIC)	8.67%	6.89%	6.64%	13.98%	14.31%	6.25%
Return on Capital Employed (ROCE)	21.50%	18.90%	13.70%	26.30%	23.70%	6.50%
Earnings Yield	2.41%	1.47%	0.90%	1.57%	3.02%	2.71%
FCF Yield	6.40%	-3.59%	-2.11%	-1.07%	-0.41%	-0.16%
Dividend Yield	2.05%	1.35%	0.68%	0.65%	1.29%	-
Payout Ratio	129.69%	70.93%	72.78%	39.95%	6.88%	15.23%
Total Shareholder Return	2.02%	1.35%	0.68%	0.65%	1.29%	-

Updated Feb 3, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.